PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.42%
Negative revenue growth while ADI stands at 11.38%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-0.96%
Negative gross profit growth while ADI is at 15.03%. Joel Greenblatt would examine cost competitiveness or demand decline.
-0.65%
Negative EBIT growth while ADI is at 40.51%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-2.38%
Negative operating income growth while ADI is at 40.51%. Joel Greenblatt would press for urgent turnaround measures.
21.82%
Net income growth at 50-75% of ADI's 39.64%. Martin Whitman would question fundamental disadvantages in expenses or demand.
14.29%
EPS growth under 50% of ADI's 33.33%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
15.00%
Diluted EPS growth under 50% of ADI's 36.36%. Michael Burry would worry about an eroding competitive position or excessive dilution.
4.86%
Share count expansion well above ADI's 3.41%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
5.55%
Diluted share count expanding well above ADI's 1.54%. Michael Burry would fear significant dilution to existing owners' stakes.
-7.44%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
71.52%
OCF growth above 1.5x ADI's 43.89%. David Dodd would confirm a clear edge in underlying cash generation.
221.43%
FCF growth above 1.5x ADI's 42.78%. David Dodd would verify if the firm’s strategic investments yield superior returns.
2.56%
10Y revenue/share CAGR under 50% of ADI's 148.43%. Michael Burry would suspect a lasting competitive disadvantage.
-18.47%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-10.52%
Negative 3Y CAGR while ADI stands at 21.14%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
17.47%
5Y OCF/share CAGR at 50-75% of ADI's 31.09%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
212.82%
3Y OCF/share CAGR above 1.5x ADI's 134.75%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
309.18%
Net income/share CAGR at 50-75% of ADI's 426.89%. Martin Whitman might question if the firm’s product or cost base lags behind.
90.17%
5Y net income/share CAGR above 1.5x ADI's 10.53%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
346.95%
3Y net income/share CAGR above 1.5x ADI's 21.59%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
112.72%
10Y equity/share CAGR at 50-75% of ADI's 205.32%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
143.50%
5Y equity/share CAGR above 1.5x ADI's 22.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
73.87%
3Y equity/share CAGR at 75-90% of ADI's 84.50%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
74.53%
Dividend/share CAGR of 74.53% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
31.98%
Dividend/share CAGR of 31.98% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-9.70%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
16.07%
AR growth well above ADI's 11.82%. Michael Burry fears inflated revenue or higher default risk in the near future.
9.29%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
19.47%
Asset growth above 1.5x ADI's 7.08%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
12.42%
BV/share growth above 1.5x ADI's 1.85%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
16.35%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-4.11%
Our R&D shrinks while ADI invests at 8.40%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
10.71%
SG&A growth well above ADI's 10.98%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.